UNICREDIT BANK/PUT/ABBVIE/150/0.1/19.03.25 Share Price

Warrant

DE000HD4FK92

Real-time BOERSE MUENCHEN 20:41:10 01/07/2024 BST
0.5 EUR -1.96% Intraday chart for UNICREDIT BANK/PUT/ABBVIE/150/0.1/19.03.25

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 0.5 -1.96%
28/06/24 0.51 -3.77%
27/06/24 0.53 +10.42%
26/06/24 0.48 -2.04%
25/06/24 0.49 +4.26%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 08:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD4FK9
ISINDE000HD4FK92
Date issued 08/04/2024
Strike 150 $
Maturity 19/03/2025 (261 Days)
Parity 10 : 1
Emission price 0.77
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.93
Lowest since issue 0.47
Delta-0.23x
Omega 7.076
Premium14.96x
Gearing31.04x
Moneyness 0.8826
Difference Strike -20.37 $
Difference Strike %-13.58%
Spread 0.02
Spread %3.85%
Theoretical value 0.5100
Implied Volatility 25.89 %
Total Loss Probability 70.09 %
Intrinsic value 0.000000
Present value 0.5100
Break even 144.52 €
Theta-0.01x
Vega0.04x
Rho-0.02x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.5 USD
Average target price
183.2 USD
Spread / Average Target
+6.83%
Consensus